Business Description
Akeso Inc
ISIN : KYG0146B1032
Share Class Description:
FRA:4RY: Ordinary SharesCompare
Compare
Traded in other countries / regions
09926.Hong KongAKESF.USA4RY.Germany IPO Date
2020-04-27Description
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.64 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 1.38 | |||||
| Interest Coverage | 24.91 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 6.56 | |||||
| Beneish M-Score | 0.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 8.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -23.81 | |||||
| Future 3-5Y Total Revenue Growth Rate | 37.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.46 | |||||
| 9-Day RSI | 56.31 | |||||
| 14-Day RSI | 55.64 | |||||
| 6-1 Month Momentum % | 7.55 | |||||
| 12-1 Month Momentum % | 12.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.71 | |||||
| Quick Ratio | 4.39 | |||||
| Cash Ratio | 4.06 | |||||
| Days Inventory | 939.18 | |||||
| Days Sales Outstanding | 22.06 | |||||
| Days Payable | 858.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.2 | |||||
| Shareholder Yield % | -2.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.06 | |||||
| Operating Margin % | 47.87 | |||||
| Net Margin % | 44.81 | |||||
| FCF Margin % | 35.18 | |||||
| ROE % | 48.46 | |||||
| ROA % | 25.56 | |||||
| ROIC % | 62.1 | |||||
| ROC (Joel Greenblatt) % | 76.5 | |||||
| ROCE % | 30.03 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.7 | |||||
| PE Ratio without NRI | 19.19 | |||||
| Price-to-Owner-Earnings | 19.5 | |||||
| PS Ratio | 8.37 | |||||
| PB Ratio | 8.11 | |||||
| Price-to-Tangible-Book | 8.66 | |||||
| Price-to-Free-Cash-Flow | 23.86 | |||||
| Price-to-Operating-Cash-Flow | 15.36 | |||||
| EV-to-EBIT | 18.23 | |||||
| EV-to-Forward-EBIT | -71.01 | |||||
| EV-to-EBITDA | 17.03 | |||||
| EV-to-Revenue | 8.18 | |||||
| EV-to-Forward-Revenue | 13.81 | |||||
| EV-to-FCF | 23.36 | |||||
| Price-to-Graham-Number | 2.7 | |||||
| Price-to-Net-Current-Asset-Value | 32.22 | |||||
| Price-to-Net-Cash | 96.67 | |||||
| Earnings Yield (Greenblatt) % | 5.49 | |||||
| FCF Yield % | 4.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Akeso Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 582.979 | ||
| EPS (TTM) (€) | 0.312 | ||
| Beta | -0.25 | ||
| Volatility % | 33.22 | ||
| 14-Day RSI | 55.64 | ||
| 14-Day ATR (€) | 0.187019 | ||
| 20-Day SMA (€) | 5.5775 | ||
| 12-1 Month Momentum % | 12.87 | ||
| 52-Week Range (€) | 3.62 - 6.05 | ||
| Shares Outstanding (Mil) | 865.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akeso Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akeso Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Akeso Inc Frequently Asked Questions
What is Akeso Inc(FRA:4RY)'s stock price today?
The current price of FRA:4RY is €5.80. The 52 week high of FRA:4RY is €6.05 and 52 week low is €3.62.
When is next earnings date of Akeso Inc(FRA:4RY)?
The next earnings date of Akeso Inc(FRA:4RY) is 2024-09-26 Est..
Does Akeso Inc(FRA:4RY) pay dividends? If so, how much?
Akeso Inc(FRA:4RY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers